Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in UNITED STATES :
sales of $45.80 billion
of which 100%
was pharmaceutical products),
Bristol-Myers Squibb Company
of which 28%
was Prioritized Brands-Revlimid), and
Merck & Co. , Inc.
of which 90%
was Merck Pharmaceutical).
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Pfizer Inc. totalled
an increase of 60.8%
from the $11.80 billion in sales at the company during the second quarter of 2020.
This was the biggest same quarter rise in sales at Pfizer Inc. in the previous 35 quarters.
During the first two
quarters of 2021, sales totalled $33.56 billion, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Pfizer Inc. were $41.91 billion.
decrease of 19.0%
versus 2019, when the company's sales were $51.75 billion.